Supernus, Indivior US merger waiting period set to expire Sept. 21
( September 11, 2026, 21:37 GMT | Official Statement) -- MLex Summary: Supernus and Indivior filed their US premerger forms to antitrust law enforcers on Aug. 20. The pharmaceutical companies anticipate that their merger waiting period will expire on Sept. 21, unless regulators opt to shorten or extend that timeline, according to paperwork submitted to the Securities and Exchange Commission.See SEC filing excerpt below....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.